These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12877903)

  • 1. Effects of folic acid supplementation on inflammatory and thrombogenic markers in chronic smokers. A randomised controlled trial.
    Mangoni AA; Arya R; Ford E; Asonganyi B; Sherwood RA; Ouldred E; Swift CG; Jackson SH
    Thromb Res; 2003 Apr; 110(1):13-7. PubMed ID: 12877903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid enhances endothelial function and reduces blood pressure in smokers: a randomized controlled trial.
    Mangoni AA; Sherwood RA; Swift CG; Jackson SH
    J Intern Med; 2002 Dec; 252(6):497-503. PubMed ID: 12472909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
    Lip GY; Lowe GD; Rumley A; Dunn FG
    Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.
    Dusitanond P; Eikelboom JW; Hankey GJ; Thom J; Gilmore G; Loh K; Yi Q; Klijn CJ; Langton P; van Bockxmeer FM; Baker R; Jamrozik K
    Stroke; 2005 Jan; 36(1):144-6. PubMed ID: 15569860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients.
    Topçiu-Shufta V; Haxhibeqiri V; Begolli L; Baruti-Gafurri Z; Veseli S; Haxhibeqiri S; Miftari R; Kurti L; Avdiu D
    Med Arch; 2015 Aug; 69(4):232-5. PubMed ID: 26543308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid improves endothelial dysfunction in type 2 diabetes--an effect independent of homocysteine-lowering.
    Title LM; Ur E; Giddens K; McQueen MJ; Nassar BA
    Vasc Med; 2006 May; 11(2):101-9. PubMed ID: 16886840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
    Li-Saw-Hee FL; Blann AD; Lip GY
    Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults.
    Klerk M; Durga J; Schouten EG; Kluft C; Kok FJ; Verhoef P
    Thromb Haemost; 2005 Jul; 94(1):96-100. PubMed ID: 16113791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease.
    Thambyrajah J; Landray MJ; Jones HJ; McGlynn FJ; Wheeler DC; Townend JN
    J Am Coll Cardiol; 2001 Jun; 37(7):1858-63. PubMed ID: 11401123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of short-term folic acid supplementation on insulin sensitivity and inflammatory markers in overweight subjects.
    Solini A; Santini E; Ferrannini E
    Int J Obes (Lond); 2006 Aug; 30(8):1197-202. PubMed ID: 16491109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trial.
    Vermeulen EG; Rauwerda JA; van den Berg M; de Jong SC; Schalkwijk C; Twisk JW; Stehouwer CD
    Eur J Clin Invest; 2003 Mar; 33(3):209-15. PubMed ID: 12641538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No effect of folic acid on markers of endothelial dysfunction or inflammation in patients with type 2 diabetes mellitus and mild hyperhomocysteinaemia.
    Spoelstra-de MA; Brouwer CB; Terheggen F; Bollen JM; Stehouwer CD; Smulders YM
    Neth J Med; 2004; 62(7):246-53. PubMed ID: 15554600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B vitamin status and inflammatory markers.
    Folsom AR; Desvarieux M; Nieto FJ; Boland LL; Ballantyne CM; Chambless LE
    Atherosclerosis; 2003 Jul; 169(1):169-74. PubMed ID: 12860264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of homocysteine-lowering nutrients on blood lipids: results from four randomised, placebo-controlled studies in healthy humans.
    Olthof MR; van Vliet T; Verhoef P; Zock PL; Katan MB
    PLoS Med; 2005 May; 2(5):e135. PubMed ID: 15916468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation.
    Klerk M; Verhoef P; Verbruggen B; Schouten EG; Blom HJ; Bos GM; den Heijer M
    Thromb Haemost; 2002 Aug; 88(2):230-5. PubMed ID: 12195694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.
    Mangoni AA; Sherwood RA; Asonganyi B; Swift CG; Thomas S; Jackson SH
    Am J Hypertens; 2005 Feb; 18(2 Pt 1):220-6. PubMed ID: 15752950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial.
    Durga J; van Tits LJ; Schouten EG; Kok FJ; Verhoef P
    Arch Intern Med; 2005 Jun; 165(12):1388-94. PubMed ID: 15983288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced lung function in patients with abdominal aortic aneurysm is associated with activation of inflammation and hemostasis, not smoking or cardiovascular disease.
    Fowkes FG; Anandan CL; Lee AJ; Smith FB; Tzoulaki I; Rumley A; Powell JT; Lowe GD
    J Vasc Surg; 2006 Mar; 43(3):474-80. PubMed ID: 16520158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of homocysteine reduction by B-vitamin supplementation on inflammatory markers.
    Peeters AC; van Aken BE; Blom HJ; Reitsma PH; den Heijer M
    Clin Chem Lab Med; 2007; 45(1):54-8. PubMed ID: 17243915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.